We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
(+9.2%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,536
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$89.2M |
| 2 |
Flutter Entertainment
FLUT
|
+$43.9M |
| 3 |
Okta
OKTA
|
+$32.1M |
| 4 |
Chewy
CHWY
|
+$31.8M |
| 5 |
Coinbase
COIN
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$91M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$75.5M |
| 3 |
Amazon
AMZN
|
+$71.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$71.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$68.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.83% |
| 2 | Financials | 13.86% |
| 3 | Consumer Discretionary | 10.9% |
| 4 | Healthcare | 9.41% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Sable Offshore Corp
SOC
$672M
| $2.18M | ﹤0.01% |
99,053
+27,238
| +38% | +$634K |
|
1827
Ouster
OUST
$2.93B
| $2.18M | ﹤0.01% |
89,768
+8,293
| +10% | +$101K |
|
1828
Matthews International
MATW
$600M
| $2.17M | ﹤0.01% |
90,744
+1,031
| +1% | +$21.7K |
|
1829
Celldex Therapeutics
CLDX
$2.46B
| $2.17M | ﹤0.01% |
106,599
+8,333
| +8% | +$162K |
|
1830
QuantumScape Corp
QS
$2.82B
| $2.16M | ﹤0.01% |
321,802
+10,013
| +3% | +$42.3K |
|
|
MRC
1831
DELISTED
MRC Global
MRC
| $2.16M | ﹤0.01% |
157,501
+6,563
| +4% | +$79.1K |
|
1832
SunCoke Energy
SXC
$799M
| $2.15M | ﹤0.01% |
250,097
+8,121
| +3% | +$70.4K |
|
1833
CG Oncology
CGON
$6.14B
| $2.14M | ﹤0.01% |
82,424
+7,735
| +10% | +$186K |
|
|
APGE
1834
DELISTED
Apogee Therapeutics
APGE
| $2.14M | ﹤0.01% |
49,216
-5,169
| -10% | -$197K |
|
1835
Birkenstock
BIRK
$5.35B
| $2.13M | ﹤0.01% |
43,405
+11,448
| +36% | +$588K |
|
1836
Deluxe
DLX
$1.08B
| $2.13M | ﹤0.01% |
133,881
+3,680
| +3% | +$55.4K |
|
1837
Insteel Industries
IIIN
$560M
| $2.13M | ﹤0.01% |
57,157
+992
| +2% | +$33.1K |
|
1838
HSBC
HSBC
$342B
| $2.12M | ﹤0.01% |
34,921
+672
| +2% | +$38.3K |
|
1839
Grid Dynamics Holdings
GDYN
$620M
| $2.12M | ﹤0.01% |
183,251
+16,202
| +10% | +$213K |
|
|
APLS
1840
DELISTED
Apellis Pharmaceuticals
APLS
| $2.11M | ﹤0.01% |
122,002
-2,452
| -2% | -$45.4K |
|
1841
ACM Research
ACMR
$5.25B
| $2.11M | ﹤0.01% |
81,465
+5,049
| +7% | +$114K |
|
|
HAPN
1842
Happen Inc
HAPN
$1.74B
| $2.11M | ﹤0.01% |
175,222
+6,442
| +4% | +$66.9K |
|
1843
Astronics
ATRO
$2.85B
| $2.1M | ﹤0.01% |
75,341
+2,020
| +3% | +$47.2K |
|
1844
Spectrum Brands
SPB
$1.89B
| $2.09M | ﹤0.01% |
39,524
+11,420
| +41% | +$681K |
|
1845
Ocular Therapeutix
OCUL
$1.72B
| $2.09M | ﹤0.01% |
225,548
+2,433
| +1% | +$19K |
|
1846
Evolent Health
EVH
$396M
| $2.09M | ﹤0.01% |
185,865
+15,947
| +9% | +$146K |
|
|
ACH
1847
Accendra Health
ACH
$46.6M
| $2.09M | ﹤0.01% |
229,629
+6,309
| +3% | +$46.5K |
|
1848
Helen of Troy
HELE
$658M
| $2.09M | ﹤0.01% |
73,507
+1,366
| +2% | +$41.9K |
|
1849
Blue Bird Corp
BLBD
$1.78B
| $2.08M | ﹤0.01% |
48,279
+3,277
| +7% | +$125K |
|
1850
Dream Finders Homes
DFH
$984M
| $2.08M | ﹤0.01% |
82,881
+7,198
| +10% | +$162K |
|
Similar funds
RhumbLine Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,536 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
- RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
- RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
- RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
- RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
- RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.